Breaking News Instant updates and real-time market news.

2020-03-17 17:22:59 OBLN Obalon Therapeutics $0.83 / -0.07 (-7.78%) 17:22 03/17/20 03/17 17:22 03/17/20 17:22	Obalon Therapeutics suspends new patient sales at retail treatment centers Obalon Therapeutics announced that it has temporarily suspended sales of its novel weight loss treatment to new patients at its existing retail treatment centers in San Diego and Orange County, California as a precaution against the spread of the coronavirus. The retail treatment centers will continue to fully treat and care for patients already in treatment with the Obalon Balloon System, and non-essential personnel will work remotely.
OBLN Obalon Therapeutics $0.83 / -0.07 (-7.78%) 04/08/19 Canaccord Obalon Therapeutics downgraded to Hold from Buy at Canaccord

2020-03-17 17:22:59

OBLN

Obalon Therapeutics

$0.83 / -0.07 (-7.78%)

17:22

03/17/20

03/17

17:22

03/17/20

17:22

Obalon Therapeutics suspends new patient sales at retail treatment centers

Obalon Therapeutics announced that it has temporarily suspended sales of its novel weight loss treatment to new patients at its existing retail treatment centers in San Diego and Orange County, California as a precaution against the spread of the coronavirus. The retail treatment centers will continue to fully treat and care for patients already in treatment with the Obalon Balloon System, and non-essential personnel will work remotely.

OBLN Obalon Therapeutics

$0.83 / -0.07 (-7.78%)

04/08/19 Canaccord: Obalon Therapeutics downgraded to Hold from Buy at Canaccord

TODAY'S FREE FLY STORIES

Recommendations	FireEye price target raised to $19 from $17 at Barclays » 07:00 01/21/21 01/21 07:00 01/21/21 07:00 FEYE FireEye $22.39 / +0.2 (+0.90%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FEYE FireEye $22.39 / +0.2 (+0.90%) 12/28/20 FireEye director sells 50K shares of common stock 12/11/20 FireEye adds Blackstone senior managing director to board as deal closes 12/08/20 FireEye falls 8% to $14.26 per share after disclosing cyber attack in 8-K filing 12/08/20 FireEye discloses attack by 'sophisticated cyber threat actor' FEYE FireEye $22.39 / +0.2 (+0.90%) 01/12/21 Mizuho FireEye price target raised to $21 from $17 at Mizuho 01/08/21 Morgan Stanley FireEye price target raised to $19 from $14 at Morgan Stanley 01/08/21 Goldman Sachs FireEye price target raised to $25 from $17 at Goldman Sachs 01/05/21 Piper Sandler FireEye price target raised to $22 from $16 at Piper Sandler FEYE FireEye $22.39 / +0.2 (+0.90%) 10/27/20 FireEye sees FY20 EPS 28c-30c, consensus 25c 10/27/20 FireEye sees Q4 EPS 9c-11c, consensus 10c 10/27/20 FireEye reports Q EPS 11c, consensus 7c 10/27/20 Notable companies reporting after market close FEYE FireEye $22.39 / +0.2 (+0.90%) 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says 01/11/21 FBI investigating Russian-linked postcard sent to FireEye CEO, Reuters reports 12/24/20 Suspected Russian hack on agencies failed to breach CrowdStrike, Reuters reports 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says FEYE FireEye $22.39 / +0.2 (+0.90%) 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 12/08/20 Fly Intel: After-Hours Movers 11/20/20 Fly Intel: Wall Street's top stories for Friday 11/20/20 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/02/21 FireEye - FEYE FEYE FireEye $22.39 / +0.2 (+0.90%) 12/28/20 FireEye call volume above normal and directionally bullish 12/24/20 Unusually active option classes on open December 24th 12/18/20 FireEye call volume above normal and directionally bullish 12/18/20 Unusually active option classes on open December 18th
Recommendations	Citizens Financial price target raised to $49 from $44 at Barclays » 07:00 01/21/21 01/21 07:00 01/21/21 07:00 CFG Citizens Financial $40.08 / -0.75 (-1.84%) Barclays analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CFG Citizens Financial $40.08 / -0.75 (-1.84%) 01/20/21 Citizens Financial sees high single digit decrease in FY21 NIM 01/20/21 Citizens Financial board approves $750M common stock repurchase program 01/20/21 Citizens Financial: 'Well positioned to benefit from economic recovery in 2021' 01/20/21 Citizens Financial reports CET1 capital ratio 10.0% at December 31, 2020 CFG Citizens Financial $40.08 / -0.75 (-1.84%) 06:29 Today RBC Capital Citizens Financial price target raised to $45 from $29 at RBC Capital 01/12/21 UBS UBS downgrades Citizens on revenue headwinds, Wells new top pick 01/11/21 UBS Citizens Financial downgraded to Neutral from Buy at UBS 01/06/21 Deutsche Bank Citizens Financial price target raised to $41 from $31 at Deutsche Bank CFG Citizens Financial $40.08 / -0.75 (-1.84%) 01/20/21 Citizens Financial reports Q4 underlying EPS $1.04, consensus 91c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/16/20 Citizens Financial reports Q3 underlying EPS 73c, consensus 74c CFG Citizens Financial $40.08 / -0.75 (-1.84%) 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says CFG Citizens Financial $40.08 / -0.75 (-1.84%) 10/16/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum 04/16/21 Citizens Financial - CFG
Recommendations	BorgWarner price target raised to $41 from $39 at Barclays » 06:59 01/21/21 01/21 06:59 01/21/21 06:59 BWA BorgWarner $40.88 / +1.59 (+4.05%) Barclays analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BWA BorgWarner $40.88 / +1.59 (+4.05%) 10/22/20 BorgWarner collaborating with Michigan university on connected vehicle project 10/07/20 Simpson Manufacturing to replace Delphi Technologies in S&P 400 at open on 10/7 10/02/20 BorgWarner-backed Romeo said in talks to come public via SPAC deal 10/01/20 Simpson Manufacturing to replace Delphi Technologies in S&P 400 at open on 10/7 BWA BorgWarner $40.88 / +1.59 (+4.05%) 01/20/21 Deutsche Bank BorgWarner named 'Catalyst Call: Buy Idea' at Deutsche Bank 11/12/20 Wolfe Research BorgWarner downgraded to Peer Perform from Outperform at Wolfe Research 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 Morgan Stanley BorgWarner downgraded to Underweight from Equal Weight at Morgan Stanley BWA BorgWarner $40.88 / +1.59 (+4.05%) 10/29/20 BorgWarner raises FY20 revenue view to $9.7B-$9.85B from $8B-$8.4B 10/29/20 BorgWarner sees Q4 revenue $3.46B-$3.61B, consensus $3.05B 10/29/20 BorgWarner reports Q3 adj. EPS 88c, consensus 77c 10/28/20 Notable companies reporting before tomorrow's open BWA BorgWarner $40.88 / +1.59 (+4.05%) 10/02/20 RMG in discussions to make Romeo Systems public through merger, Bloomberg says BWA BorgWarner $40.88 / +1.59 (+4.05%) 11/04/20 Amazon, AMD upgrades among today's top calls on Wall Street 02/11/21 BorgWarner - BWA BWA BorgWarner $40.88 / +1.59 (+4.05%) 11/19/20 Unusual call flow in option market yesterday
Hot Stocks	Boston Scientific to acquire Preventice Solutions for $925M in cash upfront » 06:59 01/21/21 01/21 06:59 01/21/21 06:59 BSX Boston Scientific $36.65 / +0.38 (+1.05%) Boston Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/11/21 Boston Scientific announces Lotus Edge recall, sees $225M-$300M of charges 12/14/20 Boston Scientific says stipulation of dismissal filed in Nevro patent case 12/14/20 Nevro to conclude its Boston Scientific lawsuit in DC area 12/01/20 Boston Scientific to sell BTG Specialty Pharmaceuticals business for $800M BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/12/21 Piper Sandler Piper says Boston Scientific pullback an opportunity to build positions 12/23/20 Piper Sandler Boston Scientific a name to own at current share levels, says Piper Sandler 12/15/20 Goldman Sachs Boston Scientific downgraded to Buy from Conviction Buy at Goldman Sachs BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/12/21 Boston Scientific sees FY20 revenue $9.91B, consensus $10.08B 01/12/21 Boston Scientific reports preliminary Q4 revenue $2.71B, consensus $2.86B 10/28/20 Boston Scientific reports Q3 adj. EPS 37c, consensus 25c 10/27/20 Notable companies reporting before tomorrow's open 22 May BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: Pre-market Movers 02/03/21 Boston Scientific - BSX BSX Boston Scientific $36.65 / +0.38 (+1.05%) 10/14/20 Boston Scientific put volume heavy and directionally bearish 10/07/20 Boston Scientific put volume heavy and directionally bearish 08/31/20 Boston Scientific put volume heavy and directionally bearish 08/21/20 Boston Scientific call volume above normal and directionally bullish
Recommendations	Morgan Stanley price target raised to $78 from $55 at RBC Capital » 06:59 01/21/21 01/21 06:59 01/21/21 06:59 MS Morgan Stanley $74.83 / -0.16 (-0.21%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 Morgan Stanley expects net new assets to remain above historical levels 01/20/21 Morgan Stanley doesn't see any change to policy rates in the near-term 01/20/21 Morgan Stanley: LT goal is for wealth management to generate margin of over 30% 01/20/21 Morgan Stanley CEO: 2021 to be a transition year MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 BMO Capital Morgan Stanley price target raised to $81 from $78 at BMO Capital 01/11/21 Piper Sandler Morgan Stanley price target raised to $76 from $54 at Piper Sandler 01/06/21 Deutsche Bank Morgan Stanley price target raised to $68 from $53 at Deutsche Bank 01/04/21 Fly Intel: Top five analyst upgrades MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 Morgan Stanley reports Q4 EPS $1.81, consensus $1.27 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/05/21 Oatly planning 2021 initial public offering, CNBC reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 12/22/20 'James Bond' studio MGM Holdings exploring sale, WSJ reports MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 02/24/21 22nd Annual Virtual Financial Services Forum MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/15/21 Unusual call flow in option market yesterday 01/14/21 $1.3M call seller in Morgan Stanley opens two week position into earnings 01/12/21 Unusual call flow in option market yesterday 01/11/21 Diagonal call spread in Morgan Stanley rolls $16M premium position

Hot Stocks	Travelers reports book value per share of $115.68, up 14% from year-end 2019 » 06:58 01/21/21 01/21 06:58 01/21/21 06:58 TRV Travelers $145.04 / +1.5 (+1.05%) Reports adjusted book… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TRV Travelers $145.04 / +1.5 (+1.05%) 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% 10/20/20 Travelers reports Q3 return on equity of 12.1%, core return on equity 13.5% 10/20/20 Travelers reports Q3 adj. book value per share $94.89 TRV Travelers $145.04 / +1.5 (+1.05%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed TRV Travelers $145.04 / +1.5 (+1.05%) 06:57 Today Travelers reports Q4 core EPS $4.91, consensus $3.18 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) TRV Travelers $145.04 / +1.5 (+1.05%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today Travelers - TRV
Earnings	Travelers reports Q4 core EPS $4.91, consensus $3.18 » 06:57 01/21/21 01/21 06:57 01/21/21 06:57 TRV Travelers $145.04 / +1.5 (+1.05%) Reports Q4 revenue $8.4B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TRV Travelers $145.04 / +1.5 (+1.05%) 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% 10/20/20 Travelers reports Q3 return on equity of 12.1%, core return on equity 13.5% 10/20/20 Travelers reports Q3 adj. book value per share $94.89 TRV Travelers $145.04 / +1.5 (+1.05%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) TRV Travelers $145.04 / +1.5 (+1.05%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today Travelers - TRV
Upgrade	Fluor upgraded to Buy from Hold at Vertical Research » 06:57 01/21/21 01/21 06:57 01/21/21 06:57 FLR Fluor $20.62 / -0.355 (-1.69%) Vertical Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FLR Fluor $20.62 / -0.355 (-1.69%) 01/11/21 Fluor awarded reimbursable services contract from UAMPS 01/11/21 Fluor announces new business segments, initiates plans to sell Stork 12/15/20 Fluor's Stork awarded 26-month maintenance contract extension by Sitech 12/10/20 Fluor says current with all financial filings and debt requirements FLR Fluor $20.62 / -0.355 (-1.69%) 01/19/21 Citi Fluor price target raised to $22 from $19 at Citi 12/11/20 DA Davidson Fluor price target raised to $15 from $12 at DA Davidson 04/27/20 Citi Fluor downgraded to Neutral from Buy at Citi 04/27/20 UBS Fluor downgraded to Neutral from Buy at UBS FLR Fluor $20.62 / -0.355 (-1.69%) 12/10/20 Fluor reports Q3 EPS 14c, consensus 27c 11/12/20 Fluor reports Q2 EPS (19c), consensus 20c 10/22/20 Fluor reports Q1 EPS ($1.22), consensus 26c 09/25/20 Fluor suspends all prior 2020 guidance, provides update FLR Fluor $20.62 / -0.355 (-1.69%) 11/12/20 Fly Intel: Pre-market Movers 09/25/20 Fly Intel: Wall Street's top stories for Friday 09/25/20 Fly Intel: Wall Street's top stories at midday 09/25/20 Fly Intel: Pre-market Movers 02/26/21 Fluor - FLR 01/28/21 Fluor Corporation FLR Fluor $20.62 / -0.355 (-1.69%) 01/12/21 Early notable gainers among liquid option names on January 12th 11/18/20 Early notable gainers among liquid option names on November 18th 11/02/20 Early notable gainers among liquid option names on November 2nd 10/07/20 Fluor call volume above normal and directionally bullish
Upgrade	Oppenheimer upgrades 'uniquely positioned' Freshpet to Outperform » 06:55 01/21/21 01/21 06:55 01/21/21 06:55 FRPT Freshpet $146.47 / +2.39 (+1.66%) , SBH Sally Beauty $14.39 / +0.585 (+4.24%) , UTZ Utz Brands $23.31 / +1.55 (+7.12%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 09/24/20 Freshpet completes CFO transition with appointment of Heather Pomerantz 08/31/20 Freshpet CFO Kassar sells 10,000 common shares 08/14/20 Freshpet launches multi-year corporate governance plan 08/03/20 Freshpet appoints Thembi Machaba as SVP, human resources SBH Sally Beauty $14.39 / +0.585 (+4.24%) 11/19/20 Sally Beauty announces launch of Buy Online, Pick Up In-Store program 11/17/20 Sysco appoints Aaron Alt as CFO 11/17/20 Sally Beauty names Mary Beth Edwards as Chief Information Officer 11/17/20 Sally Beauty CFO Aaron Alt to leave company, Marlo Cormier to succeed UTZ Utz Brands $23.31 / +1.55 (+7.12%) 01/11/21 Utz Brands to acquire Vitner's brand assets for $25M, sees accretion 12/14/20 Utz Brands completes acquisition of On The Border 11/23/20 Utz Brands CEO: We're really excited about the Truco acquisition 11/12/20 Utz Brands expects Truco to generate about $195M in net sales in FY20 FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 05:25 Today Oppenheimer Freshpet upgraded to Outperform from Perform at Oppenheimer 01/19/21 Stephens Freshpet initiated with an Overweight at Stephens 01/19/21 JPMorgan Freshpet price target raised to $170 from $160 at JPMorgan 01/14/21 Truist Freshpet price target raised to $140 from $120 at Truist SBH Sally Beauty $14.39 / +0.585 (+4.24%) 01/20/21 Morgan Stanley Sally Beauty upgraded to Equal Weight from Underweight at Morgan Stanley 06/04/20 Oppenheimer Sally Beauty upgraded to Outperform at Oppenheimer 06/04/20 Oppenheimer Sally Beauty upgraded to Outperform from Perform at Oppenheimer 04/27/20 DA Davidson Sally Beauty price target lowered to $10 from $14.50 at DA Davidson UTZ Utz Brands $23.31 / +1.55 (+7.12%) 01/20/21 Citi Utz Brands price target raised to $26 from $21 at Citi 01/19/21 Stephens Utz Brands initiated with an Overweight at Stephens 12/22/20 Piper Sandler Utz Brands price target raised to $25 from $22 at Piper Sandler 12/21/20 Goldman Sachs Utz Brands reinstated with a Neutral at Goldman Sachs FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 01/13/21 Freshpet sees Q4 revenue $84.5M, consensus $88.41M 01/13/21 Freshpet sees Q4 net sales $84.5M, consensus $88.41M 01/13/21 Freshpet sees FY20 net sales $318.8M, consensus $322.73M 11/02/20 Freshpet backs FY20 revenue view $320M, consensus $321.89M SBH Sally Beauty $14.39 / +0.585 (+4.24%) 11/12/20 Sally Beauty not providing formal FY21 guidance at this time 11/12/20 Sally Beauty reports Q4 adjusted EPS 63c, consensus 56c 11/11/20 Notable companies reporting before tomorrow's open 11/11/20 Notable companies reporting before tomorrow's open UTZ Utz Brands $23.31 / +1.55 (+7.12%) 11/05/20 Utz Brands sees FY20 revenue growth 10%-11%, consensus $949.32M 11/05/20 Utz Brands reports Q3 revenue $248.0M, consensus $246.11M 27 Feb FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 11/02/20 Fly Intel: After-Hours Movers 08/03/20 Fly Intel: After-Hours Movers SBH Sally Beauty $14.39 / +0.585 (+4.24%) 11/12/20 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: After-Hours Movers UTZ Utz Brands $23.31 / +1.55 (+7.12%) 11/13/20 Disney upgrade among today's top calls on Wall Street 09/21/20 Fly Intel: After-Hours Movers 01/28/21 Sally Beauty Holdings Inc.
Recommendations	Lithium Americas price target raised to C$20 from C$13 at BMO Capital » 06:55 01/21/21 01/21 06:55 01/21/21 06:55 LAC Lithium Americas $22.24 / -4.565 (-17.03%) BMO Capital analyst Joel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/20/21 Lithium Americas falls -17.8% 01/20/21 Lithium Americas falls -13.9% 01/20/21 Lithium Americas falls -14.9% 01/20/21 Lithium Americas trading resumes LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $22.24 / -4.565 (-17.03%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names

Upgrade	Occidental Petroleum upgraded to Hold from Underperform at Jefferies » 06:55 01/21/21 01/21 06:55 01/21/21 06:55 OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 12/21/20 Tesla set to join S&P 500 & S&P 100 at open on 12/21 12/15/20 Occidental subsidiary awarded tundra carbon storage consulting services contract 12/11/20 Tesla set to join S&P 500 & S&P 100 at open on 12/21 11/13/20 Icahn reduces stake in Herbalife, boosts stake in Xerox OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 01/19/21 Societe Generale Societe Generale starts Occidental at Hold after doubling of shares 01/19/21 Societe Generale Occidental Petroleum initiated with a Hold at Societe Generale 01/14/21 Barclays Occidental Petroleum price target raised to $23 from $18 at Barclays 01/11/21 Mizuho Occidental Petroleum upgraded to Buy from Neutral at Mizuho OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 11/09/20 Occidental Petroleum reports adjusted Q3 (84c), consensus (72c) 08/10/20 Occidental sees Q4 production of 1,300-1,330 Mboed 08/10/20 Occidental sees Q3 production of 1,200-1,250 Mboed 08/10/20 Occidental sees second half capital spend of 700M-$900M OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 07/29/20 Occidental in talks to sell $4.5B in assets to Pertamina, Bloomberg reports OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 12/21/20 Tesla under pressure on first trading day on S&P 500 Index 08/10/20 Fly Intel: After-Hours Movers 02/17/21 Occidental Petroleum - OXY OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 01/12/21 Early notable gainers among liquid option names on January 12th 01/05/21 Occidental Petroleum call volume above normal and directionally bullish 01/05/21 Early notable gainers among liquid option names on January 5th 12/23/20 Occidental Petroleum call volume above normal and directionally bullish
Initiation	Neste initiated with a Hold at Jefferies » 06:53 01/21/21 01/21 06:53 01/21/21 06:53 NTOIY Neste $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NTOIY Neste $0.00 / + (+0.00%) 11/03/20 Bunge to sell Rotterdam facility to Neste for EUR 258M in cash NTOIY Neste $0.00 / + (+0.00%) 01/15/21 JPMorgan Neste price target raised to EUR 55 from EUR 52 at JPMorgan 01/08/21 Redburn Neste downgraded to Neutral from Buy at Redburn 12/02/20 JPMorgan Neste price target raised to EUR 52 from EUR 38 at JPMorgan 12/02/20 UBS Neste price target raised to EUR 54 from EUR 37 at UBS
Recommendations	FirstEnergy price target lowered to $29 from $30 at Mizuho » 06:53 01/21/21 01/21 06:53 01/21/21 06:53 FE FirstEnergy $31.33 / +0.22 (+0.71%) Mizuho analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FE FirstEnergy $31.33 / +0.22 (+0.71%) 01/19/21 FirstEnergy utilities issue RFP for solar energy credits 01/05/21 FirstEnergy appoints Hyun Park as Chief Legal Officer 11/17/20 FirstEnergy receives not in compliance letter from NYSE 10/29/20 FirstEnergy announces termination of CEO Charles Jones FE FirstEnergy $31.33 / +0.22 (+0.71%) 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo FirstEnergy downgraded to Underweight from Equal Weight at Wells Fargo 12/01/20 Wells Fargo FirstEnergy downgraded to Equal Weight amid investigations at Wells Fargo 12/01/20 Wells Fargo FirstEnergy downgraded to Equal Weight from Overweight at Wells Fargo FE FirstEnergy $31.33 / +0.22 (+0.71%) 11/02/20 FirstEnergy reports Q3 adj. EPS 84c, consensus 79c 07/23/20 FirstEnergy reiterates long-term growth rate projections 07/23/20 FirstEnergy backs FY20 EPS view $2.40-$2.60, consensus $2.48 07/23/20 FirstEnergy sees Q3 EPS 73c-83c, consensus 76c FE FirstEnergy $31.33 / +0.22 (+0.71%) 11/16/20 FBI raids home of PUCO Chairman Sam Randazzo, Cincinnati Enquirer reports 10/14/20 Federal prosecutors asked Energy Harbor for documents, WSJ reports 09/23/20 FirstEnergy sued by Ohio AG for 'pattern of corrupt activity,' Bloomberg says 07/21/20 Ohio House Speaker arrested in $60M bribery case, Cleveland.com reports FE FirstEnergy $31.33 / +0.22 (+0.71%) 10/30/20 Fly Intel: Wall Street's top stories at midday 07/23/20 Fly Intel: After-Hours Movers 07/22/20 IBM, Coca-Cola upgrades among today's top calls on Wall Street 07/22/20 Fly Intel: Pre-market Movers FE FirstEnergy $31.33 / +0.22 (+0.71%) 11/24/20 FirstEnergy put volume heavy and directionally bearish 11/20/20 FirstEnergy put volume heavy and directionally bearish 11/19/20 FirstEnergy put volume heavy and directionally bearish 11/10/20 FirstEnergy put volume heavy and directionally bearish
Recommendations	Citi adds Tandem, removes Guardant from 'Value Creators' list » 06:52 01/21/21 01/21 06:52 01/21/21 06:52 TNDM TNDM / + , GH Guardant Health $163.38 / +3.38 (+2.11%) Citi strategist Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events TNDM GH TNDM TNDM / + 11/23/20 Tandem Diabetes enters new agreements with DexCom 11/23/20 Tandem says Health Canada approves t:slim X2 Insulin pump GH Guardant Health $163.38 / +3.38 (+2.11%) 01/19/21 Guardant Health CEO sells 150K shares of common stock 01/18/21 Guardant Health announces partnership with Vall d'Hebron Institute of Oncology 01/11/21 Guardant Health to launch Guardant Reveal colon cancer liquid biopsy test 12/11/20 Guardant Health names Michael Bell as new CFO, succeeding Derek Bertocci TNDM GH TNDM TNDM / + 12/15/20 Wells Fargo Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up 12/15/20 Wells Fargo Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo 11/06/20 Piper Sandler Tandem Diabetes price target raised to $132 from $125 at Piper Sandler 10/16/20 Citi Citi opens 'positive catalyst watch' on DexCom GH Guardant Health $163.38 / +3.38 (+2.11%) 01/14/21 Canaccord Natera price target raised to $125 from $112 at Canaccord 01/12/21 Canaccord Guardant Health price target raised to $170 from $145 at Canaccord 01/11/21 Fly Intel: Top five analyst initiations 01/11/21 Stifel Guardant Health initiated with a Buy at Stifel TNDM GH TNDM TNDM / + 11/05/20 Tandem Diabetes raises FY20 revenue view to $465M-$475M from $450M-$465M 11/05/20 Tandem Diabetes reports Q3 EPS (15c), consensus (10c) 07/30/20 Tandem Diabetes reinstates FY20 revenue view to $450M-$465M, consensus $417.2M 07/30/20 Tandem Diabetes reports Q2 EPS (45c), consensus (24c) GH Guardant Health $163.38 / +3.38 (+2.11%) 11/05/20 Guardant Health reports Q3 GAAP EPS (78c), consensus (38c) 08/06/20 Guardant Health reports Q2 EPS (57c), consensus (38c) 07 Oct 02 Jun TNDM GH TNDM TNDM / + 08/11/20 Medtronic rises following acquisition of insulin pen maker Companion 07/31/20 Fly Intel: Alphabet downgrade among today's top calls on Wall Street GH Guardant Health $163.38 / +3.38 (+2.11%) 10/06/20 Fly Intel: After-Hours Movers 02/24/21 Tandem Diabetes - TNDM
Earnings	BankUnited reports Q4 EPS 89c, consensus 70c » 06:51 01/21/21 01/21 06:51 01/21/21 06:51 BKU BankUnited $38.48 / -0.34 (-0.88%) Reports Q4 net recovery… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BKU BankUnited $38.48 / -0.34 (-0.88%) 09/01/20 BankUnited to replace Lithia Motors in S&P 600 at open on 9/1 08/25/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices 08/25/20 BankUnited to replace Lithia Motors in S&P 600 at open on 9/1 08/14/20 BankUnited hires Kevin Malcolm as General Counsel BKU BankUnited $38.48 / -0.34 (-0.88%) 01/08/21 UBS BankUnited downgraded to Neutral from Buy at UBS 01/05/21 RBC Capital BankUnited price target raised to $39 from $29 at RBC Capital 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global BankUnited initiated with a Buy at Seaport Global BKU BankUnited $38.48 / -0.34 (-0.88%) 10/28/20 BankUnited reports Q3 EPS 70c, consensus 63c 07/29/20 BankUnited reports Q2 EPS 80c, consensus 22c BKU BankUnited $38.48 / -0.34 (-0.88%) 08/25/20 Fly Intel: After-Hours Movers 09:00 Today BankUnited - BKU

Initiation	Galp Energia initiated with a Hold at Jefferies » 06:51 01/21/21 01/21 06:51 01/21/21 06:51 GLPEY Galp Energia $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GLPEY Galp Energia $0.00 / + (+0.00%) 01/15/21 JPMorgan Galp Energia price target lowered to EUR 11 from EUR 11.50 at JPMorgan 01/14/21 Credit Suisse Galp Energia price target lowered to EUR 13 from EUR 13.40 at Credit Suisse 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/14/21 Societe Generale Galp Energia downgraded to Hold from Buy at Societe Generale
Initiation	Repsol initiated with a Hold at Jefferies » 06:49 01/21/21 01/21 06:49 01/21/21 06:49 REPYY Repsol $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research REPYY Repsol $0.00 / + (+0.00%) 01/15/21 JPMorgan Repsol price target raised to EUR 8.50 from EUR 8 at JPMorgan 01/14/21 Credit Suisse Repsol price target raised to EUR 10 from EUR 9.50 at Credit Suisse 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/11/21 Morgan Stanley Repsol price target raised to EUR 8.55 from EUR 7.50 at Morgan Stanley
Recommendations	UBS sees 'golden' risk reward for McDonald's » 06:49 01/21/21 01/21 06:49 01/21/21 06:49 MCD McDonald's / + UBS analyst Dennis Geiger… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MCD McDonald's / + 12/07/20 Allete announces renewable energy agreement with McDonald's 12/07/20 Apex Clean Energy announces two PPA with McDonald's 11/19/20 Jack in the Box CEO says team working on new chicken program 11/09/20 Beyond Meat says worked very hard to develop McDonald's McPlant burger MCD McDonald's / + 01/19/21 Goldman Sachs McDonald's initiated with a Buy at Goldman Sachs 01/07/21 Fly Intel: Top five analyst upgrades 01/07/21 Oppenheimer Opco upgrades McDonald's to Outperform for first time since 2021 01/07/21 Oppenheimer McDonald's upgraded to Outperform from Perform at Oppenheimer MCD McDonald's / + 11/09/20 McDonald's reports Q3 ex-items EPS $2.22, consensus $1.90 07/28/20 McDonald's reports Q2 EPS 66c, consensus 74c 07/27/20 Notable companies reporting before tomorrow's open 07/27/20 Notable companies reporting before tomorrow's open MCD McDonald's / + 01/04/21 McDonald's to launch 3 new chicken sandwiches in U.S. in February, Reuters says 12/09/20 McDonald's franchisees plan to raise Happy Meal prices, WSJ reports 11/16/20 McDonald's to increase inspections to ward off 'Covid fatigue,' NYP reports 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' MCD McDonald's / + 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 01/05/21 Tesla downgrade, McDonald's initiation among today's top calls on Wall Street 01/04/21 Airbnb, DoorDash coverage initiations among today's top calls on Wall Street 01/28/21 McDonald's - MCD 01/22/21 Mapping Your Corporate Social Responsibility MCD McDonald's / + 09/09/20 Unusually active option classes on open September 9th 09/02/20 McDonald's call volume above normal and directionally bullish 08/17/20 Unusually active option classes on open August 17th 07/28/20 Unusually active option classes on open July 28th
Upgrade	Ramsay Health Care upgraded to Buy from Neutral at Citi » 06:49 01/21/21 01/21 06:49 01/21/21 06:49 RMSYF Ramsay Health Care $0.00 / + (+0.00%) Citi analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RMSYF Ramsay Health Care $0.00 / + (+0.00%) 01/15/21 Goldman Sachs Ramsay Health Care upgraded to Conviction Buy from Neutral at Goldman Sachs 04/23/20 Citi Ramsay Health Care downgraded to Neutral from Buy at Citi 03/27/20 Goldman Sachs Ramsay Health Care upgraded to Neutral from Sell at Goldman Sachs
Upgrade	CSL upgraded to Buy from Neutral at Citi » 06:48 01/21/21 01/21 06:48 01/21/21 06:48 CSLLY CSL $0.00 / + (+0.00%) Citi analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly CSLLY CSL $0.00 / + (+0.00%) 11/02/20 CSL granted Orphan Drug Designation for CSL889 from FDA, EC 08/24/20 Grifols jumps after FDA issues emergency use authorization for plasma CSLLY CSL $0.00 / + (+0.00%) 11/11/20 JPMorgan CSL upgraded to Overweight from Neutral at JPMorgan 08/20/20 Citi CSL downgraded to Neutral from Buy at Citi 05/28/20 Citi CSL upgraded to Buy from Neutral at Citi 04/14/20 Citi CSL downgraded to Neutral from Buy at Citi CSLLY CSL $0.00 / + (+0.00%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports CSLLY CSL $0.00 / + (+0.00%) 08/24/20 Fly Intel: Wall Street's top stories for Monday 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID

Initiation	OMV AG initiated with a Buy at Jefferies » 06:48 01/21/21 01/21 06:48 01/21/21 06:48 OMVKY OMV AG $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research OMVKY OMV AG $0.00 / + (+0.00%) 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out OMVKY OMV AG $0.00 / + (+0.00%) 01/15/21 JPMorgan OMV AG price target raised to EUR 44 from EUR 40 at JPMorgan 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/11/21 Morgan Stanley OMV AG price target raised to EUR 44 from EUR 36.70 at Morgan Stanley 12/09/20 Berenberg OMV AG price target raised to EUR 38 from EUR 34 at Berenberg
Upgrade	Cochlear upgraded to Neutral from Sell at Citi » 06:48 01/21/21 01/21 06:48 01/21/21 06:48 CHEOY Cochlear $0.00 / + (+0.00%) Citi analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CHEOY Cochlear $0.00 / + (+0.00%) 03/17/20 Citi Cochlear upgraded to Neutral from Sell at Citi 03/12/20 Jefferies Cochlear upgraded to Hold from Underperform at Jefferies 02/20/20 Goldman Sachs Cochlear downgraded to Sell from Neutral at Goldman Sachs 02/18/20 Morgan Stanley ResMed downgraded to Equal Weight on valuation at Morgan Stanley
Initiation	Eni SpA initiated with a Hold at Jefferies » 06:46 01/21/21 01/21 06:46 01/21/21 06:46 E Eni SpA $21.68 / +0.2 (+0.93%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research E Eni SpA $21.68 / +0.2 (+0.93%) 01/15/21 JPMorgan Eni SpA price target raised to EUR 9 from EUR 8.50 at JPMorgan 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/13/21 Credit Suisse Eni SpA price target raised to EUR 10 from EUR 9.20 at Credit Suisse 01/11/21 Morgan Stanley Eni SpA price target raised to EUR 8.20 from EUR 6 at Morgan Stanley
Recommendations	Callon Petroleum price target raised to $16 from $6 at Citi » 06:46 01/21/21 01/21 06:46 01/21/21 06:46 CPE Callon Petroleum $14.86 / -0.82 (-5.23%) Citi analyst Brian Downey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 12/04/20 Callon Petroleum rises 26.0% 12/04/20 Callon Petroleum rises 12.0% 11/03/20 Callon Petroleum sees FY20 production 100-101 Mboe/d 10/01/20 Callon announces $170M in asset monetizations, $300M from notes issuance CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 12/31/20 Truist Callon Petroleum price target raised to $14 from $6 at Truist 12/17/20 RBC Capital Callon Petroleum price target raised to $20 from $16 at RBC Capital 11/04/20 MKM Partners Callon Petroleum price target raised to $15 from $10 at MKM Partners 11/04/20 Northland Callon Petroleum price target lowered to $7 from $10 at Northland CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 11/03/20 Callon Petroleum reports Q3 adj. EPS 64c, consensus 0c 08/04/20 Callon Petroleum reports Q2 adj. EPS 1c, consensus (5c) CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 10/01/20 Fly Intel: Pre-market Movers 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 02/25/21 Callon Petroleum - CPE CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 11/25/20 Largest borrow rate increases among liquid names 11/06/20 Largest borrow rate increases among liquid names
Hot Stocks	Store Capital announces January rent collections of 91% » 06:46 01/21/21 01/21 06:46 01/21/21 06:46 STOR Store Capital $31.36 / +0.62 (+2.02%) As of January 20, Store… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STOR Store Capital $31.36 / +0.62 (+2.02%) 01/11/21 Store Capital announces acquisition activity for 2020 12/22/20 Store Capital announces December rent collections of 90% 11/23/20 Store Capital announces November rent collections of 90% 10/21/20 Store Capital announces October rent collections of 90% STOR Store Capital $31.36 / +0.62 (+2.02%) 12/16/20 Baird Store Capital downgraded to Neutral from Outperform at Baird 12/11/20 Truist Store Capital price target raised to $30 from $27 at Truist 12/10/20 Wells Fargo Store Capital upgraded to Overweight from Equal Weight at Wells Fargo 12/10/20 Wells Fargo Store Capital upgraded to Overweight from Equal Weight at Wells Fargo STOR Store Capital $31.36 / +0.62 (+2.02%) 08/05/20 Store Capital reports Q2 adjusted FFO 44c, consensus 44c

Events

Earnings calls, analyst events, roadshows and more

SI
Today at 08:00

Silvergate Capital - SI Conference Calls
BEDU
Today at 08:00

Bright Scholar - BEDU Conference Calls
DFS
Today at 08:00

Discover - DFS Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
TAL
Today at 08:00

TAL Education - TAL Conference Calls
STL
Today at 08:00

Sterling Bancorp - STL Conference Calls
TFC
Today at 08:00

Truist Financial - TFC Conference Calls
CTXS
Today at 08:15

Citrix - CTXS Conference Calls
PLXS
Today at 08:30

Plexus - PLXS Conference Calls
UNP
Today at 08:45

Union Pacific - UNP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG $5.76 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Obalon Therapeutics suspends new patient sales at retail treatment centers

TODAY'S FREE FLY STORIES

Get Full Fly Access